What drug class is acetazolamide in?
Acetazolamide is a carbonic anhydrase inhibitor. It works by blocking carbonic anhydrase enzymes, which reduces bicarbonate formation and changes how the kidney handles acid-base balance and electrolytes.
What conditions is acetazolamide used for (and why its class matters)?
Because carbonic anhydrase inhibitors affect acid-base transport, acetazolamide is used in several settings, including:
- Glaucoma and ocular hypertension (to lower intraocular pressure)
- Altitude sickness prevention/treatment (to induce respiratory drive via metabolic acidosis)
- Edema related to specific causes (as a mild diuretic effect via altered renal electrolyte handling)
- Certain seizure disorders as an adjunct (it can help by altering cerebral metabolism and acid-base balance)
Is acetazolamide a “diuretic” or a “glaucoma medication”?
Acetazolamide is commonly described by its mechanism (carbonic anhydrase inhibitor). It can act like a diuretic at the kidney, but it is not in the same class as loop, thiazide, or potassium-sparing diuretics; its diuretic effect comes from carbonic anhydrase inhibition rather than from blocking a specific segment transporter like those other classes.
What’s the drug class compared with other carbonic anhydrase inhibitors?
Within this enzyme-inhibitor group, acetazolamide is the best-known systemic agent. Other carbonic anhydrase inhibitors include topical eye drops (used mainly for eye pressure) such as dorzolamide and brinzolamide, which share the same general enzyme-target class but are typically used differently because of route and dosing strategy.
Are there major patent/class sourcing pages for acetazolamide?
If you are tracking acetazolamide products by patenting or exclusivity, DrugPatentWatch.com is a useful starting point for locating filings and related brand/generic context: https://www.drugpatentwatch.com/